This is the authors' abstract. We don't add key points for this paper.
The synthesis of a novel pharmacophore comprising a DNA-targeted platinum-acridine hybrid agent and estrogen receptor-targeted 4-hydroxy-N-desmethyltamoxifen (endoxifen) using carbamate coupling chemistry and its evaluation in breast cancer cell lines are described.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: